Novartis Foundation Symposium 217 – Genetics and Tuberculosis

Derek J. Chadwick is the editor for Genetics and Tuberculosis and other scientific titles. Gail Cardew is the editor for Genetics and Tuberculosis and other scientific titles.

Host Genetic Susceptibility to Human Tuberculosis (R. Bellamy & A. Hill). The Epidemiology of Tuberculosis in South Africa (P. Donald). Using Conventional and Molecular Epidemiological Analyses to Target Tuberculosis Control Interventions in a Low Incidence Area (P. Hopewell). Vaccines, Genes and Trials (P. Fine). Immunological and Endocrinological Characteristics of Tuberculosis that Provide Opportunities for Immunotherapeutic Intervention (G. Rook & R. Hernandez-Pando). Recombinant Interleukin 2 Adjunctive Therapy in Multidrug-Resistant Tuberculosis (B. Johnson, et al.). Cellular and Genetic Mechanisms Underlying Susceptibility of Animal Models to Tuberculosis Infection (I. Orme). Susceptibility to Tuberculosis as a Complex Genetic Trait: Analysis Using Recombinant Congenic Strains of Mice (I. Kramnik, et al.). ENDOCYTIC TRAFFICKING AND THE MYCOBACTERIAL VACUOLE. Signals that Regulate the Host Response to Mycobacterium tuberculosis (A. Beyers, et al.). Analysis of the Genome of Mycobacterium tuberculosis H37Rv (S. Cole & B. Barrell). Bacterial Genetics and Strain Variation (P. van Helden). Antibiotic Resistance in Mycobacteria (J. Davies). Mechanisms for Isoniazid Action and Resistance (L. Miesel, et al.). THE BIOSYNTHESIS OF CELL WALL MOLECULES. The Impact of Genomics on the Search for Novel Tuberculosis Drugs (K. Duncan). DNA Vaccines Against Tuberculosis (J. Ulmer, et al.). Summary (D. Young). Epilogue (S. Benatar). Indexes.